Inventor · disambiguated record
Jeanne Menez-Jamet
Also filed as: MENEZ-JAMET JEANNE
5 granted patents·8 pending applications·39 citations·filing 2007–2024
78Inventor score
Files withVAXON BIOTECH7KOSMATOPOULOS KOSTANTINOS KOSTAS3KRIPTIC PHARMACEUTICALS LTD2PASTEUR INSTITUT1
Top patents by PatentIndex Score
13 records- 0190US8003773B2Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopesPASTEUR INSTITUT·Filed 2007·Granted Aug 23, 2011·25 cites·12 claims
- 0283US8900600B2Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapyKOSMATOPOULOS KOSTANTINOS KOSTAS·Filed 2009·Granted Dec 2, 2014·4 cites·4 claims
- 0378US10024868B2Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapyKOSMATOPOULOS KOSTANTINOS KOSTAS·Filed 2009·Granted Jul 17, 2018·5 cites·9 claims
- 0478US8465747B2Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapyKOSMATOPOULOS KOSTANTINOS KOSTAS·Filed 2007·Granted Jun 18, 2013·4 cites·19 claims
- 0566US12048737B2Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-A*0201-positive patient having a non-immunogenic tumor expressing tertKRIPTIC PHARMACEUTICALS LTD·Filed 2018·Granted Jul 30, 2024·1 cites·12 claims
- 0660US2024325511A1Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Cancer in a HLA-A*0201-Positive Patient Having a Non-Immunogenic Tumor Expressing TertKRIPTIC PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0756US2017000866A1Method for emulsifying a triepitope peptide with montanide and kits for performing the sameVAXON BIOTECH·Filed 2014·Application pending·0 cites
- 0853US2019151427A1Method for Emulsifying a Triepitope Peptide with Montanide and Kits for Performing the SameVAXON BIOTECH·Filed 2019·Application pending·0 cites
- 0946US2013266598A1Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For ImmunotherapyVAXON BIOTECH·Filed 2013·Application pending·0 cites
- 1043US2022249642A1Combination of Markers for Predicting the Response to Vx-001VAXON BIOTECH·Filed 2020·Application pending·0 cites
- 1143US2017202936A1Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For ImmunotherapyVAXON BIOTECH·Filed 2017·Application pending·0 cites
- 1240US2020079819A1Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker PatientVAXON BIOTECH·Filed 2018·Application pending·0 cites
- 1325US2017157228A1Immunogenic Polypeptide Composed of HLA-B7 Restricted Tumor Antigen-Derived Optimized Cryptic Peptides, and Uses ThereofVAXON BIOTECH·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →